GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HCmed Innovations Co Ltd (ROCO:6934) » Definitions » 3-Year EBITDA Growth Rate

HCmed Innovations Co (ROCO:6934) 3-Year EBITDA Growth Rate : 0.00% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is HCmed Innovations Co 3-Year EBITDA Growth Rate?

HCmed Innovations Co's EBITDA per Share for the six months ended in Jun. 2024 was NT$-1.87.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of HCmed Innovations Co's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, HCmed Innovations Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HCmed Innovations Co's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HCmed Innovations Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where HCmed Innovations Co's 3-Year EBITDA Growth Rate falls into.



HCmed Innovations Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


HCmed Innovations Co  (ROCO:6934) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


HCmed Innovations Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of HCmed Innovations Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


HCmed Innovations Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Dunhua S. Road, Rm.B, 10th floor., No.319, Sec.2, Taipei, TWN, 106033
HCmed Innovations Co Ltd is focused on inhalation therapy to create integrated drug nebulizer combination products featuring nebulization therapeutic drugs that include small molecule synthetics and large molecule biologics, as either solutions, suspensions, and even difficult-to-deliver high viscosity drugs. Its product include Pulmogine and AdheResp.

HCmed Innovations Co Headlines

No Headlines